Hemogenyx Pharmaceuticals' Reverse Merger Round

Hemogenyx Pharmaceuticals raised a round of funding on September 20, 2017. Investors include Silver Falcon.

HemoGenyx is developing a new type of treatment for leukemia, lymphoma, and other blood disorders using a special class of cells harvested from a patient's liver that make bone marrow transplants more…

Articles about Hemogenyx Pharmaceuticals' Reverse Merger Round: